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T cell-mediated autoimmune diseases such as type 1 diabetes (T1D)
are believed to be the result in part of inefficient negative selection
of self-specific thymocytes. However, the events regulating thymic
negative selection are not fully understood. In the current study,
we demonstrate that nonobese diabetic (NOD) mice lacking ex-
pression of the Mer tyrosine kinase (MerTK) have reduced inflam-
mation of the pancreatic islets and fail to develop diabetes.
Furthermore, NOD mice deficient in MerTK expression (Mer/)
exhibit a reduced frequency of  cell-specific T cells independent of
immunoregulatory effectors. The establishment of bone marrow
chimeric mice demonstrated that the block in  cell autoimmunity
required hematopoietic-derived cells lacking MerTK expression.
Notably, fetal thymic organ cultures and self-peptide administra-
tion showed increased thymic negative selection in Mer/ mice.
Finally, thymic dendritic cells (DC) prepared from Mer/ mice
exhibited an increased capacity to induce thymocyte apoptosis in
a peptide-specific manner in vitro. These findings provide evidence
for a unique mechanism involving MerTK-mediated regulation of
thymocyte negative selection and thymic DC, and suggest a role for
MerTK in contributing to  cell autoimmunity.
dendritic cells  receptor tyrosine kinase  type 1 diabetes
The breakdown of central and/or peripheral tolerance (1–7)can result in the development of T cell mediated autoim-
mune diseases such as type 1 diabetes (T1D), multiple sclerosis,
and rheumatoid arthritis (8–11). The failure in T cell tolerance
is generally influenced by a number of genes, most of which have
yet to be identified (12). In the nonobese diabetic (NOD) mouse,
a spontaneous model for T1D, both inefficient negative selection
and dysregulation of peripheral tolerance mechanisms contrib-
ute to the development and activation, respectively, of patho-
genic T cells that target the insulin producing  cells found in the
islets of Langerhans (13). Inefficient negative selection in NOD
mice is partly the result of the peptide binding properties of the
MHC class II molecule IAg7, and the relative insensitivity of
NOD CD4CD8 double-positive (DP) thymocytes to apopto-
sis-inducing events (9, 14, 15). One intriguing possibility is that
the efficiency of negative selection is also regulated by the
activation and/or functional state of medullary thymic epithelial
cells (mTEC) and resident dendritic cells (DC). For instance
events that regulate the avidity between DP thymocytes and
mTEC and/or thymic DC may influence the efficiency of neg-
ative selection. This is likely similar to mechanisms in the
periphery.
The activation and maturation status of peripheral DC is critical
for determining the outcome of a T cell response (16). Immature
DC found under homeostatic conditions are characterized by low
levels of MHC and T cell costimulatory molecules such as CD40,
CD80, and CD86, and typically mediate clonal anergy/deletion of
naïve T cells (17). However, upon activation and subsequent
maturation, DC upregulate MHC and costimulatory molecules and
secrete proinflammatory cytokines to promote robust expansion
and effector T cell differentiation (17).
Our group and others demonstrated that the Mer tyrosine
kinase (MerTK) negatively regulates antigen presenting cells
(APC) such as DC and macrophages (M) (18–21). MerTK
belongs to a family of receptor tyrosine kinases (RTKs) con-
sisting of Axl and Tyro3 (22, 23). Mice lacking expression of all
3 RTKs have hyperactive APC in the periphery, resulting in
systemic autoimmunity characterized by T cell infiltrates in
several tissues (24). In addition to DC and M, MerTK is
expressed by NK T cells, NK cells, epithelia and endothelia cell
types, and B cells, but not T cells (25, 26). MerTK is necessary
for efficient clearance of apoptotic cells (AC) by certain subsets
of M and retinal pigment epithelial cells (27–29). Recently, we
demonstrated that MerTK is critical for transducing signals that
mediate the inhibitory effect of AC on immature DC (18). The
binding of AC by immature DC blocks subsequent activation and
establishes a stable ‘‘tolergenic’’ DC phenotype. Interestingly,
the gene encoding MerTK is found in a T1D genetic suscepti-
bility locus in mice. Mertk is located in the 95% confidence
interval of Idd13 on chromosome (Chr.) 2 (30). Idd13 consists of
at least 2 subloci, one of which contains the 2 microglobulin
gene (30). Currently, it is not known whether MerTK contributes
to T1D susceptibility.
To assess the role of MerTK in the development of T1D, the
MerTK ‘‘kinase-dead’’ mutation (MertkKD) was introgressed
onto the NOD genetic background. Our findings support a key
role for MerTK in immunoregulation of thymic negative selec-
tion. NOD mice lacking MerTK expression (Mer/) were
protected from diabetes because of enhanced negative selection
and the depletion of pathogenic  cell-specific T precursors.
These findings identify a novel mechanism of thymic immune
homeostasis and suggest a role for MerTK in contributing to
T1D.
Results
MerTK-Deficient NOD Mice Remain Diabetes Free. To determine the
effect of MerTK deficiency on the progression of spontaneous
T1D, NOD mice with the MerTKKD null mutation were estab-
lished (18). Briefly, C57BL/6.MerTKKD were bred with NOD
mice, and the MertkKD gene introgressed 11 generations onto the
NOD genetic background (18). The original MerTKKD founder
mouse was generated using a 129/Ola embryonic stem cell line.
Microsatellite analyses mapped MertkKD within a 17-cM span of
129/Ola-derived Chr. 2 DNA (18). Both 129/Ola and NOD mice
share the diabetogenic allele of B2m (B2ma) that is contained
within the congenic interval. This allele sharing was confirmed
Author contributions: M.A.W. and R.T. designed research; M.A.W., R.R.F., Y.W., Z.Y., C.J.K.,
and C.E.M. performed research; H.S.E. and G.M. contributed new reagents/analytic tools;
M.A.W., C.E.M., H.S.E., G.M., B.W., and R.T. analyzed data; and M.A.W., B.W., and R.T.
wrote the paper.
The authors declare no conflict of interest.
1To whom correspondence should be addressed. E-mail: rmtisch@med.unc.edu.
This article contains supporting information online at www.pnas.org/cgi/content/full/
0900683106/DCSupplemental.
4810–4815  PNAS  March 24, 2009  vol. 106  no. 12 www.pnas.orgcgidoi10.1073pnas.0900683106
via restriction fragment length polymorphism (Fig. S1). Wild-
type (Mer/), heterozygous (Mer/), and homozygous
(Mer/) female littermates were monitored for diabetes. The
time of onset and frequency of diabetes were similar between
Mer/ and Mer/ female littermates (Fig. 1A). Strikingly,
none of the Mer/ female littermates developed diabetes up to
52 weeks of age (Fig. 1 A).
Lack of diabetes correlated with a reduced frequency of cell
infiltration of the islets in Mer/ versus Mer/ female litter-
mates. The majority of islets in 12 (63  18% versus 33  15%)
and 17-wk-old (65  12% versus 25  8%) Mer/ but not
Mer/ female mice were free of insulitis (Fig. 1B). Further-
more, the composition of the islet infiltrate differed markedly
between Mer/ and Mer/ mice. Insulitis in 12-wk-old Mer/
islets consisted mostly of T cells with 43  13% CD4 and 22 
5% CD8, with B cells making up to 34  10% of the infiltrating
lymphocytes (Fig. 1C). In contrast, Mer/ islets were mostly
infiltrated with B cells (51  14%) and CD8 T cells (37  11%),
while CD4 T cells (11  4%) were reduced in the infiltrate (Fig.
1C). These data indicate that insulitis is altered and overt
diabetes prevented in Mer/ female mice.
Because Mertk is found within the Idd13 interval it was
important to rule out that diabetes resistance in Mer/ mice was
independent of MertkKD and the result of an unidentified gene
found in the 17-cM region of 129/Ola Chr. 2. NOD mice were
established using a speed congenic approach which contained a
44-cM span of wild-type 129/Ola Chr. 2 including Idd13 and
Mertk (Table S1). No significant difference in the time of onset
or frequency of diabetes was observed between female wild-type
NOD mice (NOD-129.Chr2/) compared to a fifth backcross
generation of NOD female littermates heterozygous (NOD-
129.Chr2/) or homozygous (NOD-129.Chr2/) for the 129/
Ola Chr. 2 segment (Fig. 1D). Therefore the lack of diabetes in
Mer/ mice was MertkKD dependent.
 Cell-Specific T Cell Reactivity Is Reduced in Mer/ Mice Indepen-
dent of Peripheral Immunoregulation. To further investigate the
autoimmune status of Mer/ mice, the frequency and nature of
 cell-specific CD4 and CD8 T cells infiltrating the islets was
examined. CD4 and CD8 T cells prepared from the islets of
12-wk-old Mer/ female mice exhibited a typical type 1 effector
T cell profile characterized by a high frequency of IFN secreting
T cells in response to a panel of  cell autoantigens (Fig. 2A) and
no detectable IL-4 or IL-10 secreting T cells (data not shown).
In contrast, in Mer/ female littermates the frequency of
islet-infiltrating CD4 and CD8 T cells secreting IFN in
response to the panel of  cell autoantigens was significantly
reduced (Fig. 2 A). Similar to Mer/ mice, however, no increase
in IL-4 or IL-10 secreting  cell-specific CD4 or CD8 T cells
was detected via ELISPOT in the islets, pancreatic lymph nodes
(PLN), or spleen of Mer/ mice (data not shown). Staining with
Fig. 1. Diabetes and insulitis are blocked in Mer/ mice. (A) Diabetes
incidence in Mer/, Mer/, and Mer/ female mice. *, P  0.001 versus
Mer/ and Mer/ mice. (B) Severity of insulitis was determined in H&E
stained pancreatic sections (5 female mice/group) and scored for the percent-
age of islets with no visible insulitis (black), peri-insulitis (white), or intra-
insulitis (gray). †, P  0.004; ‡, P  0.003; §, P  0.016; and ¶, P  0.003. (C) The
percentage of CD19 B cells, CD4 T cells, and CD8 T cells determined in islets
from 12-wk-old female Mer/ (n  14) and Mer/ (n  7) mice by flow
cytometry. (D) Diabetes incidence in groups of 5 NOD-129.Chr2/, NOD-
129.Chr2/, and NOD-129.Chr2/ female littermates.
Fig. 2.  cell-specific T cells are reduced in Mer/ islets. (A) The frequency of islet infiltrating  cell-specific CD3 T cells was determined by ELISPOT. Data
represent 5 mice/group. *, P  0.011; †, P  0.001; and ‡, P  0.042. (B) Flow cytometric analysis of NRPV7-specific CD8 T cells from islets of Mer/ and Mer/
mice. Islets were pooled from 5 mice/group. (C) Diabetes incidence in Mer/ and Mer/ mice after transfer of BDC CD4 T cells. Flow cytometric determination
of the absolute number (D) and frequency (E) of CD4 CD25 FoxP3 T cells in PLN of Mer/ and Mer/ mice. Results are representative of at least 3 experiments.









H2Kd tetramers complexed with the diabetogenic NRP-V7
mimetic peptide demonstrated a reduced frequency of NRP-
V7-specific CD8 T cells in the islet infiltrates of 12-wk-old
Mer/ (2.3%) compared to Mer/ (9.4%) female littermates
(Fig. 2B).
The above findings indicated that the lack of diabetes in
Mer/ mice correlated with a reduced frequency of type 1 
cell-specific T effectors independent of immunoregulatory T
cells. To confirm the latter, adoptive transfer experiments were
performed. Initially, diabetes was monitored in 4-wk-old female
Mer/ or Mer/ mice receiving 5  106 diabetogenic CD4 T
cells expressing the BDC2.5 clonotypic TCR. All Mer/ and
Mer/ recipients developed diabetes within 12 days posttrans-
fer (Fig. 2C). Additionally, CD4 BDC T cells were mixed with
splenocytes from either 8-wk-old Mer/ or Mer/ mice and
then transferred into NOD.scid mice. All recipient mice devel-
oped diabetes within 4–6 days posttransfer regardless of whether
Mer/ or Mer/ splenocytes were used (data not shown). No
difference was detected in the number (Fig. 2D) or frequency
(Fig. 2E) of FoxP3-expressing CD4CD25 immunoregulatory
T cells residing in the PLN of 4-wk-old Mer/ and Mer/
female mice. These results demonstrate that Mer/ mice have
reduced  cell-specific pathogenic T cell reactivity independent
of enhanced peripheral immunoregulation.
Prevention of T1D in Mer/ Mice Is Mediated by Bone Marrow-
Derived Cells. MerTK is expressed by bone marrow (bm)-derived
cells, and epithelial and endothelial cell types (22, 23). To
determine the contribution of these cell types in preventing T1D
in Mer/ mice, bm chimeric NOD mice were established.
Initially, 8-wk-old NOD or Mer/ female mice were lethally
irradiated and reconstituted with bm prepared from NOD mice
expressing a transgene encoding green fluorescent protein
(NOD.GFP). Reconstitution with donor bm typically resulted in
80% of splenic CD4 T cells expressing GFP as measured by
flow cytometry (Fig. S2). Both NOD and Mer/ recipients
developed diabetes at a similar time of onset and frequency (Fig.
3A), indicating that nonhematopoietic cells in Mer/ recipients
were insufficient to block the development of pathogenic effec-
tors from donor NOD.GFP bm. Next, 8-wk-old NOD female
mice were irradiated and reconstituted with NOD.GFP or
Mer/.GFP bm. The majority of NOD.GFP bm recipients
developed diabetes (Fig. 3B). In contrast, all Mer/.GFP bm
recipients remained diabetes free (Fig. 3B). Lack of diabetes in
Mer/.GFP bm recipients correlated with a reduced frequency
of islet infiltrating H2Kd-NRPV7 CD8T cells relative to
NOD.GFP bm recipients 8 wk posttransfer (Fig. 3C). These data
demonstrate that reduced  cell autoimmunity in Mer/ mice
is mediated by bm-derived cells.
Thymic Negative Selection in Mer/ Mice Is Enhanced. Reduced
pathogenic T effectors in the absence of enhanced immunoregu-
lation suggested that self-tolerance in Mer/ mice was estab-
lished via increased thymic negative selection. To test this
hypothesis, fetal thymic organ cultures (FTOC) were established
from Mertk/ and Mertk/ day 13 NOD embryo donors
expressing the BDC2.5 clonotypic TCR, and cultured for 6 days
with the BDC2.5 mimetic peptide (mBDC) or a control ovalbu-
min peptide (Ova323–339). In Ova323–339-treated FTOC, no dif-
ference was detected in the frequency of DP, CD4CD8 double
negative (DN), CD4 single-positive (SP), and CD8 SP thy-
mocytes prepared from Mer/.BDC and Mer/.BDC thymic
lobes (Fig. 4A). In contrast, the frequency of DP thymocytes was
significantly reduced and a compensatory increase in CD8 SP
thymocytes detected in Mer/.BDC versus Mer/.BDC FTOC
treated with mBDC (Fig. 4A). Depletion of DP thymocytes in
mBDC-treated FTOC correlated with an increased frequency of
Fig. 3. Diabetes inhibition in Mer/ mice is mediated by bm cells. (A)
Diabetes incidence in recipient Mer/ and Mer/ mice reconstituted with
NOD.GFP bm. (B) Diabetes incidence in recipient NOD mice reconstituted with
Mer/.GFP or Mer/.GFP bm. *, P  0.001. (C) Flow cytometric analysis of
NRPV7-specific CD8 T cells from islets of recipient NOD mice reconstituted
with Mer/.GFP or Mer/.GFP bm. †, P  0.001. Results are representative of
at least 2 experiments.
Fig. 4. Thymic negative selection is enhanced in Mer/ mice. (A) Represen-
tative staining of thymocyte subsets in FTOC prepared from Mer/.BDC and
Mer/.BDC fetal donors. (Right) Graphical representation of thymocyte sub-
sets in Mer/.BDC (square) and Mer/.BDC (circle) FTOC. At least 3 thymi
were used per group. *, P  0.045; †, P  0.023; and ‡, P  0.038 (B) Flow
cytometric analysis of VAD-FMK-FITC DP thymocytes in Mer/ or Mer/
mice injected i.v. with 900 g of Ova323–339 or mBDC. (C) Graphical represen-
tation of data from 4 mice/group injected with mBDC. §, P  0.001; ¶, P 
0.001. Results are representative of at least 3 experiments.
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apoptotic DP in Mer/.BDC versus Mer/.BDC thymic lobes
(Fig. 4B).
To determine whether enhanced negative selection could also
be detected in vivo, 4-wk-old Mer/.BDC and Mer/.BDC
female mice received a single injection of 300 or 900 g of mBDC
and 6 h later apoptosis within DP thymocytes measured. Treat-
ment with mBDC induced increased apoptosis of DP thymocytes
in Mer/.BDC versus Mer/.BDC mice (Fig. 4C). Induction of
apoptosis was peptide specific because mBDC treatment of
wild-type NOD mice did not induce increased apoptosis of DP
thymocytes relative to an untreated group (data not shown).
Mer/ Thymic DC Mediate Enhanced Thymic Negative Selection in
Vitro. mTEC and DC mediate thymocyte negative selection.
Because bm-derived cells were required to prevent T1D in
Mer/ mice (Fig. 3), DC likely promoted the enhanced thymic
negative selection in Mer/ mice. To test this possibility, an
in vitro negative selection assay was used. Thymic DCs pre-
pared from Mer/ or Mer/ mice were pulsed with mBDC
or Ova322–339, cocultured with NOD.BDC thymocytes, and
apoptosis was measured in DP thymocytes. Apoptosis of DP
thymocytes was increased in cultures of mBDC-pulsed thymic
DC isolated from Mer/ versus Mer/ mice (Fig. 5A). Only
minor differences in the frequency of CD11cCD11b,
CD11cCD8, and plasmacytoid DC were detected in thymic
DC prepared from Mer/ or Mer/ mice (Fig. 5 BD).
Furthermore, no difference in surface expression of CD40,
CD80, CD86, and class II MHC (Fig. 5 BD) or PD-L1 and
OX40L (data not shown) among the 3 major thymic DC
subsets (e.g., CD11cCD11b, CD11cCD8, and
CD11cB220) was detected between Mer/, Mer/, and
Mer/ mice. These findings demonstrate that thymic DCs
lacking MerTK expression exhibit an enhanced capacity to
induce thymocyte negative selection despite no marked change
in thymic DC subsets or phenotypic markers for DC activation
and maturation.
Discussion
The events that influence the efficacy of thymic negative selec-
tion remain ill defined. The current study identifies a novel
mechanism regulating negative selection of self-specific thymo-
cytes and the development of T cell-mediated autoimmunity.
Three key observations were made in this study.
First, MerTK influences thymocyte selection. Mer/ mice
exhibited increased negative selection of  cell-specific thymo-
cytes as determined by FTOC (Fig. 4). Depletion of DP thymo-
cytes was increased 2-fold in mBDC-treated Mer/.BDC
FTOC (Fig. 4A). A similar result was obtained in vivo when
apoptosis of DP thymocytes was measured in Mer/.BDC mice
injected with mBDC (Fig. 4C). Notably, no difference in the
frequency of the respective thymocyte subsets was detected in
control FTOC prepared from Mer/.BDC and NOD.BDC
embryos, demonstrating that thymocyte development per se was
not aberrantly affected by the MerTK deficiency. Indeed, equiv-
alent T cell responses are induced in Mer/ and NOD mice
immunized with a foreign antigen (data not shown). Therefore,
the lack of MerTK expression selectively affected the repertoire
of autoreactive T precursors.
Enhanced negative selection of  cell-specific thymocytes
effectively blocked the diabetogenic response in Mer/ mice.
The pool of peripheral pathogenic T effectors was reduced in
Mer/ mice (Fig. 2) thereby altering the progression of
insulitis both quantitatively and qualitatively. This reduction in
pathogenic T cells limited  cell destruction (Fig. 1) indepen-
dent of immunoregulatory T cells (Fig. 2). The latter is
consistent with our earlier observation that a greater fre-
quency of adoptively transferred BDC2.5 CD4 T cells de-
velop into pathogenic type 1 effectors in Mer/ compared to
NOD recipients in which  cell injury is induced by strepto-
zotocin treatment (18). In addition to the islets, NOD mice
exhibit T cell-mediated autoimmunity specific for other tis-
sues. Histological analysis demonstrated reduced infiltration
of the salivary glands and large intestine in 12-wk-old Mer/
versus wild-type NOD female mice (Fig. S3), indicating that
the effect of MerTK deficiency on negative selection is not
limited to  cell-specific thymocytes. Presumably, salivary
gland and gut antigens are expressed in the thymus and are
presented more efficiently in Mer/ mice. Our findings are in
marked contrast to results for mice lacking MerTK, Axl, and
Tyro3 expression (24). In the triple knockout mice that were
on a heterogeneous genetic background, T cells were found
infiltrating several peripheral tissues. It is possible that the
deficiency of Axl and Tyro3 may alter the effects of the
MertkKD mutation on thymocyte selection. Alternatively, self-
antigens targeted by T cells in the triple knockout mice may not
be presented in the thymus, which may also explain why
C57BL/6 mice lacking MerTK expression develop lupus-like
autoimmunity with age (27).
The second key observation made in this study is that in-
creased negative selection in Mer/ mice is the result of an
enhanced capacity of thymic DC to delete thymocytes (Fig. 5A).
This conclusion is supported by results demonstrating that
diabetes is prevented in bm chimeric mice in which hematopoi-
etic-derived cells lacked MerTK expression (Fig. 3). Further-
more, mTEC and cortical TEC do not express MerTK in
wild-type NOD mice (C.J.K. and R.T., unpublished results).
Although a role for thymic M’s, which also express MerTK
cannot be ruled out, it is generally believed that the primary
function of M is to clear apoptotic cells in the thymus with little
if any participation in thymocyte negative selection. We and
Fig. 5. Mer/ thymic DCs mediate enhanced thymic negative selection. (A)
The frequency of VAD-FMK-FITC DP thymocytes after coculture with mBDC
pulsed Mer/ or Mer/ thymic DC as determined by flow cytometry. *, P 
0.029; †, P  0.002. (B–D) Flow cytometric analysis of sorted CD11c thymic DC
pooled from 10 thymi of 4-wk-old Mer/ and Mer/ mice and stained for
CD11c, CD40, CD80, CD86, and (B) CD11b, (C) CD8, and (D) B220. Results are
representative of at least 2 experiments.









others have demonstrated a critical role for MerTK in negatively
regulating DC activation and maturation (18–20, 24). MerTK is
required to induce AC-mediated inhibition of immature DC
from peripheral tissues by blocking the activation of the NF-B
pathway (18, 20). NF-B is an important transcription factor
regulating expression of a number of genes required for DC
activation, maturation, and effector function, including genes
encoding MHC classes I and II, costimulatory molecules, and
cytokines (17). Somewhat surprisingly the increased capacity of
Mer/ thymic DC to mediate DP thymocyte apoptosis did not
correspond with phenotypic changes typically associated with
DC activation or maturation (Fig. 5). For instance, elevated
expression of MHC and/or costimulatory molecules would be
expected to enhance the stimulatory function of the DC, and
therefore increase thymocyte negative selection. Initial microar-
ray experiments suggest that the mRNA expression profiles of
Mer/ versus NOD thymic DC differ, including genes associ-
ated with cell membrane structure and/or cell-to-cell interac-
tions. These proteins may affect the avidity of the interaction
between DC and thymocytes, and the efficacy of negative
selection. On the basis of our findings, we propose that MerTK
provides ‘‘tonic’’ signaling that regulates the capacity of thymic
DC to stimulate thymocytes and induce apoptotic signals that
drive negative selection. It is noteworthy that levels of expression
of tissue-specific antigens in the thymus have also been linked
with the development of autoreactive T precursors. For instance,
reduced thymic expression of insulin is believed to limit negative
selection of insulin-specific thymocytes (12). Therefore, the
efficiency of negative selection is likely to be in part influenced
by levels of tissue-specific antigens expressed in the thymus,
coupled with the stimulatory capacity of thymic DC, which is
regulated by MerTK.
Third, this study provides evidence supporting a role for
MerTK in T1D. The fact that Mertk resides within the 95%
confidence interval of Idd13 suggests that MerTK polymor-
phisms may contribute to the progression of T1D. Importantly,
Mer/ mice express the diabetogenic isoform of the B2m gene
located in Idd13, and NOD female mice homozygous for a 44-cM
segment of 129/Ola Chr. 2 DNA spanning Idd13 developed
diabetes at a similar time of onset and frequency as wild-type
NOD littermates (Fig. 1D). The latter directly demonstrates that
the lack of diabetes in Mer/ mice is in fact the result of the KD
mutation introduced into Mertk. Distinct expression profiles
and/or isoforms of MerTK may reduce the efficacy of thymic DC
to mediate negative selection, resulting in an increased fre-
quency of  cell-specific T precursors residing in the periphery.
As alluded to above, work by our group demonstrated that
MerTK also affects the APC function of peripheral DC (18).
Here, it was found that PLN DCs lacking MerTK expression
readily promote the differentiation of type 1 effectors in vivo if
a sufficient frequency of diabetogenic T precursors is present.
Therefore, MerTK may contribute to T1D by regulating the
development of pathogenic T precursors both in the thymus and
periphery.
In summary, data are provided demonstrating a unique mech-
anism in which MerTK regulates the efficiency of DC to mediate
thymic negative selection thereby influencing the development
of autoreactive T cells. In addition to T1D, MerTK may also play
a role in shaping the repertoire of pathogenic T cells in other
autoimmune diseases.
Methods
Mice. NOD/LtJ ‘‘NOD,’’ NOD.Cg-Tg(TcraBDC2.5)1Doi Tg(TcrbBDC2.5)2Doi
‘‘NOD.BDC,’’ 129P2/OlaHsd ‘‘129/Ola,’’ and NOD.GFP mice were maintained
and bred under specific pathogen-free conditions. The establishment and
genotyping of the 11th backcross generation of Mer/ mice have been
described (18). NOD-129.Chr2/ mice were established by introgressing 129/
Ola Chr. 2 DNA for 5 generations onto the NOD genetic background. Micro-
satellite analysis was performed to delineate a 44-cM segment of 129/Ola Chr.
2 containing Idd13. Mice were diagnosed as diabetic following 2 consecutive
readings of 250 mg/dL blood glucose. The Institutional Animal Care and Use
Committee of the University of North Carolina at Chapel Hill approved our use
of mice.
Isolation and Analyses of Islet-Infiltrating Cells. Pancreata were perfused with
collagenase P (Roche Diagnostics), digested at 37 °C, and islets enriched by
Ficoll gradient and then handpicked. T cells were isolated from dissociated
islets with anti-CD3 microbeads (Miltenyi Biotec). ELISPOT was carried out
as described (31) with the following modifications. Irradiated splenocytes
(5  106/well) and purified islet-infiltrating T cells (1  104/well) were
cocultured with 10 g/mL peptide for 48 h. Islet histology was carried out
as described (32). Briefly pancreata were formalin fixed, embedded in
paraffin, and sections cut 100 m apart, and stained with hematoxylin and
eosin (H&E).
Flow Cytometry. The following monoclonal antibodies used for staining were
purchased from BD Biosciences: anti-CD11c-APC, -CD4-APC, -CD4-PE, -CD8-PerCP,
-CD3-FITC, and -CD19-PE. FoxP3-expressing CD4CD25 T cells were identified
using a mouse regulatory T cell staining kit (eBioscience). H2Kd MHC class I
tetramers were prepared as described (32). Islet-infiltrating T cells were stained
with anti-CD3-FITC, -CD8-PerCP, and PE-labeled tetramer loaded with either
influenza nucleoprotein (NP) or NRP-V7. Stained cells were analyzed on a FACS-
can or FACScalibur (BD Biosciences) using Summit software (Cytomation).
Adoptive Transfer of Diabetogenic BDC CD4 T cells. CD4 T cells were isolated
from the spleens of 10- to 12-wk-old female NOD.BDC using a BD IMag CD4 T
lymphocyte enrichment set (BD Biosciences). BDC CD4 T cells were injected
i.p. (5  106 cells) into 4-wk-old Mer/ or Mer/ recipients. Alternatively, BDC
CD4 T cells were cotransferred with Mer/ or Mer/ splenocytes (5.0  106)
into NOD.scid recipients.
Bm Chimera Mice. Bm was isolated from NOD.GFP or Mer/. GFP mice. CD4
and CD8 T cells were depleted with GK1.5 and HO2.2, respectively, and rabbit
serum complement. Bm cells (2  106) were transferred i.v. into irradiated
(1000 gy) 8-wk-old Mer/ or Mer/ mice. Chimerism was confirmed by the
presence of GFP lymphocytes in peripheral blood.
FTOC. Mer/.BDC male and female mice were intercrossed and timed preg-
nancies established. Thymic lobes were removed from E13 embryos (in addi-
tion to fetal liver for genotyping), separated, and placed on Millicell culture
plate insert discs (Millipore). Millicell discs were overlaid on complete RPMI
medium 1640 (10% FCS, L-glutamine, Na-pyruvate, nonessential amino acids,
penicillin/streptomycin and -ME). After 3 days, medium containing either
Ova322–339 or mBDC (RTRPLWVRME) was replaced daily for 4 days. Thymic lobes
were dissociated and stained with VAD-FMK-FITC, anti-CD4-APC, -CD8-PerCP,
and -V4-PE (clonotypic TCR  chain of the BDC TCR).
In Vivo Thymic Selection. Four-wk-old female Mer/.BDC or Mer/.BDC mice
were injected i.v. with 300 or 900 g of Ova322–339 or mBDC in PBS. Thymi were
removed 8 h later and dissociated. Thymocytes were stained with anti-CD4-
APC, -CD8-PerCP, -V4-PE, and VAD-FMK-FITC.
In Vitro Negative Selection by Thymic DC. Thymi were isolated from 4-wk-old
Mer/ or Mer/ mice, physically disrupted, and then digested for 1 h at 37 °C in
complete RPMI medium 1640 containing collagenase D (Roche Diagnostics) and
DNase I (Sigma-Aldrich).DCswerepulsedwithOva322–339 ormBDCandisolatedby
anti-CD11c magnetic microbeads (Miltenyi), stained with anti-CD11c-APC, and
sorted with a MoFlo cell sorter (Dako). The resulting populations were routinely
95% CD11c DC. Purified peptide-pulsed DCs were cocultured with freshly
isolated NOD.BDC thymocytes (5  105) for 6 h. Thymocytes were then stained
with PE-anti-CD4, PerCP-anti-CD8, and VAD-FMK-FITC.
Statistical Analyses. Statistical analyses were performed using GraphPad Prism
software version 4. Diabetes frequencies were compared by Kaplan-Meir log
rank test. All other data were compared by unpaired Student’s t test. Findings
were considered significant with P values 0.05.
ACKNOWLEDGMENTS. This work was supported by the Juvenile Diabetes
Research Foundation (JDRF) Grant 1–2005-984 and National Institute of Al-
lergy and Infectious Diseases (NIAID) Grant AI066075 (R.T.); JDRF Grant
3–2001-860 and NIAID Grant AI056374 (C.E.M.); and NIAID Grant AI50736
(G.M.). R.R.F. is supported by a National Institutes of Health (NIH) fellowship;
C.J.K. is supported by NIH Training Grant 5T32 AI07273.
4814  www.pnas.orgcgidoi10.1073pnas.0900683106 Wallet et al.
1. Bouneaud C, Kourilsky P, Bousso P (2000) Impact of negative selection on the T cell
repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal
deletion. Immunity 13:829–840.
2. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune
tolerance. Cell 133:775–787.
3. Pechhold K, Koczwara K (2008) Immunomodulation of autoimmune diabetes by
dendritic cells. Curr Diab Rep 8:107–113.
4. Brocker T, Riedinger M, Karjalainen K (1997) Targeted expression of major histocom-
patibility complex (MHC) class II molecules demonstrates that dendritic cells can induce
negative but not positive selection of thymocytes in vivo. J Exp Med 185:541–550.
5. Delaney JR, Sykulev Y, Eisen HN, Tonegawa S (1998) Differences in the level of
expression of class I major histocompatibility complex proteins on thymic epithelial and
dendritic cells influence the decision of immature thymocytes between positive and
negative selection. Proc Natl Acad Sci USA 95:5235–5240.
6. Ashton-Rickardt P, et al. (1994) Evidence for a differential avidity model of T cell
selection in the thymus. Cell 76:651–663.
7. Anderson G, Moore N, Owen J, Jenkinson E (1996) Cellular interactions in thymocyte
development. Annu Rev Immunol 14:73–99.
8. Tisch R, McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85:291–297.
9. Kanagawa O, Martin S, Vaupel B, Carrasco-Marin E, Unanue E (1998) Autoreactivity of
T cells from nonobese diabetic mice: An I-Ag7-dependent reaction. Proc Natl Acad Sci
USA 95:1721–1724.
10. Jurewicz A, Biddison WE, Antel JP (1998) MHC class I-restricted lysis of human oligo-
dendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol
160:3056–3059.
11. Panayi GS, Lanchbury JS, Kingsley GH (1992) The importance of the T cell in initiating and
maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729–735.
12. Maier LM, Wicker LS (2005) Genetic susceptibility to type 1 diabetes. Curr Opin
Immunol 17:601–608.
13. Anderson MS, Bluestone JA (2005) The NOD mouse: A model of immune dysregulation.
Ann Rev Immunol 23:447–485.
14. Zucchelli S, et al. (2005) Defective central tolerance induction in NOD mice: Genomics
and genetics. Immunity 22:385–396.
15. Liston A, et al. (2004) Generalized resistance to thymic deletion in the NOD mouse: a
polygenic trait characterized by defective induction of Bim. Immunity 21:817–830.
16. Schuler G, Steinman RM (1985) Murine epidermal Langerhans cells mature into potent
immunostimulatory dendritic cells in vitro. J Exp Med 161:526–546.
17. Wallet MA, Sen P, Tisch R (2005) Immunoregulation of dendritic cells. Clin Med Res
3:166–175.
18. Wallet MA, et al. (2008) MerTK is required for apoptotic cell-induced T cell tolerance.
J Exp Med 205:219–232.
19. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G (2007) TAM receptors are
pleiotropic inhibitors of the innate immune response. Cell 131:1124–1136.
20. Sen P, et al. (2007) Apoptotic cells induce Mer tyrosine kinase-dependent blockade of
NF-kappaB activation in dendritic cells. Blood 109:653–660.
21. Todt JC, Hu B, Curtis JL (2004) The receptor tyrosine kinase MerTK activates phospho-
lipase C gamma2 during recognition of apoptotic thymocytes by murine macrophages.
J Leukoc Biol 75:705–713.
22. Lemke G, Rothlin CV (2008) Immunobiology of the TAM receptors. Nat Rev Immunol
8:327–336.
23. Linger RM, Keating AK, Earp HS, Graham DK (2008) TAM receptor tyrosine kinases:
Biologic functions, signaling, and potential therapeutic targeting in human cancer.
Adv Cancer Res 100:35–83.
24. Lu Q, Lemke G (2001) Homeostatic regulation of the immune system by receptor
tyrosine kinases of the Tyro 3 family. Science 293:306–311.
25. Behrens EM, et al. (2003) The mer receptor tyrosine kinase: Expression and function
suggest a role in innate immunity. Eur J Immunol 33:2160–2167.
26. Shao WH, Eisenberg RA, Cohen PL (2008) The Mer receptor tyrosine kinase is required
for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic
lupus erythematosus. J Immunol 180:7728–7735.
27. Cohen PL, et al. (2002) Delayed apoptotic cell clearance and lupus-like autoimmunity
in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 196:135–140.
28. Scott RS, et al. (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER.
Nature 411:207–211.
29. Feng W, Yasumura D, Matthes MT, LaVail MM, Vollrath D (2002) Mertk triggers uptake
of photoreceptor outer segments during phagocytosis by cultured retinal pigment
epithelial cells. J Biol Chem 277:17016–17022.
30. Serreze DV, et al. (1998) Subcongenic analysis of the Idd13 locus in NOD/Lt mice:
Evidence for several susceptibility genes including a possible diabetogenic role for beta
2-microglobulin. J Immunol 160:1472–1478.
31. Pop SM, et al. (2007) The type and frequency of immunoregulatory CD4 T cells
governs the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
Diabetes 56:1395–1402.
32. Wong CP, Li L, Frelinger JA, Tisch R (2006) Early autoimmune destruction of islet grafts
is associated with a restricted repertoire of IGRP-specific CD8 T cells in diabetic
nonobese diabetic mice. J Immunol 176:1637–1644.
Wallet et al. PNAS  March 24, 2009  vol. 106  no. 12  4815
IM
M
U
N
O
LO
G
Y
